LYON, France--(BUSINESS WIRE)--The MEDICREA Group (Paris:ALMED) (listed on Alternext by NYSE Euronext Paris), a specialist in the design, manufacture and sale of spinal implants, is publishing its sales figures for the third quarter of 2010 and its half year results approved by the Board meeting held on September the 30th.
